BSE filing, NSE: VARDHMAN. Summary written from the filing by ALFA Finder's alert engine.
More from Vardhman Concrete Ltd
All →Vardhman Concrete Annual General Meeting
Vardhman Concrete Limited held its 43rd Annual General Meeting on September 28, 2026. Shareholders considered the adoption of financial statements and the appointment of three directors.
Vardhman Concrete Other Announcement
Vardhman Concrete Ltd has announced the closure of its share transfer books from September 22, 2026, to September 28, 2026, for its 43rd Annual General Meeting.
Vardhman Concrete Annual Report
Vardhman Concrete Ltd has submitted its 43rd Annual Report for the financial year ended March 31, 2026, as required under SEBI listing regulations.
Vardhman Concrete Annual General Meeting
Vardhman Concrete Ltd has issued the notice for its 43rd Annual General Meeting, scheduled for September 28, 2026, to conduct routine business and director appointments.
Vardhman Concrete Q1 FY27 Results: Net Profit ₹0 Cr
Vardhman Concrete Ltd reported net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Vardhman Concrete Board Meeting Date
Vardhman Concrete Limited will hold a board meeting on August 14, 2026. The meeting will consider and approve unaudited standalone financial results for the June quarter.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.